Coronado Biosciences, Inc. has formed a wholly owned subsidiary, Journey Medical Corporation (JMC), to acquire and license dermatology products.

Under the leadership of Claude Maraoui, CEO, JMC will begin building a portfolio of dermatological assets focused on acne, steroid responsive dermatoses, pigmentation and antifungals for promotion to dermatologists and pediatricians. Mr. Maraoui has more than 25 years of experience in commercializing dermatology products. He was formerly Vice President, Dermatology Sales and Executive Director of Aesthetics Sales at Medicis Pharmaceutical Corporation.